|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
C12N 15/02 A61K 39/395 A61P 7/00 A61P 9/00 C07K 16/18 C12P 21/08 |
| (11) | Number of the document | 4192 |
| (13) | Kind of document | B |
| (21) | Application number | 96-140 |
| (22) | Date of filing the application | 1996-09-24 |
| (41) | Date of publication of the application | 1997-03-25 |
| (45) | Date of publication of patent | 1997-07-25 |
| (86) | Number | PCT/US95/01825 |
| Date | 1995-02-21 |
| (87) | Number | WO 95/22986 |
| Date | 1995-08-31 |
| (30) | Number | Date | Country code |
| 204015 | 1994-02-24 | US |
| (71) |
American Biogenetic Sciences, Inc.,
1375 Akron Street, Copiague, NY 11726,
US
|
| (72) |
Paul E. GARGAN, US
|
| (73) |
American Biogenetic Sciences, Inc.,
1375 Akron Street, Copiague, NY 11726,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | THE USE OF FIBRIN-SPECIFIC ANTIBODY AS AN ANTITHROMBIC AGENT |
| Payment date | Validity (years) | Amount | |
| 2001-01-25 | 7 | 560.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2002-02-21 |